# GenomAIc — One-Page Investor Summary (Research-First)

## What it is
GenomAIc is a research-grade AI system that interprets whole-genome sequencing directly from raw reads (FASTQ), fusing short- and long-read evidence and producing calibrated confidence with abstention when evidence is insufficient.

## The problem
Current genomic workflows often assume clean inputs and can be brittle in difficult genomic regions (repeats, SVs, immune loci) and in cross-platform disagreement. False confidence causes wasted validation cycles and missed discoveries.

## Why GenomAIc
- FASTQ-first: models platform noise instead of ignoring it
- Cross-tech fusion: resolves conflicts using evidence, not heuristics
- Reliability-first: explicit uncertainty + abstention + verifier loop
- Publishable benchmarks: accuracy AND calibration AND coverage

## Primary research aims (12–18 months)
Aim 1 — Evidence-grounded modeling from raw reads  
Deliverable: read→tile→memory pipeline, cross-tech alignment, stable training infra.

Aim 2 — Multi-task interpretation heads + verifier  
Deliverable: variant, splicing, regulatory, SV, phasing, reliability heads with calibration and abstention.

Aim 3 — Benchmark suite + reproducibility  
Deliverable: public-facing evaluation harness (risk-coverage curves, concordance), ablations, paper-ready artifacts.

## Milestones
- M1 (0–3 mo): synthetic & small public benchmarks; Stage 1 denoise
- M2 (3–6 mo): cross-tech alignment + tile consensus
- M3 (6–12 mo): multi-task heads + verifier; calibration & abstention
- M4 (12–18 mo): full benchmark report + preprint submission

## Market pull (where value accumulates)
- Rare disease research workflows
- High-complexity regions where confidence matters
- Translational research needing fewer wet-lab cycles

## Team needs
- ML systems + distributed training
- Genomics domain expertise + benchmarking discipline
- Data governance / security engineering
